(Q46796012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

A 6-month, open-label study of memantine in patients with frontotemporal dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

frontotemporal dementia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Robert Perneczky

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2

Hans Förstl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Corina Pohl

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alexander Kurz

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Geriatric Psychiatry

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

754-759

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

The FAB: a Frontal Assessment Battery at bedside.

1 January 2020

cites work

1 reference

Survival in frontotemporal dementia

21 January 2018

1 reference

Behavioral disorders in the frontal and temporal variants of frontotemporal dementia

21 January 2018

1 reference

Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia

21 January 2018

1 reference

The natural history of temporal variant frontotemporal dementia

21 January 2018

1 reference

Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank

21 January 2018

1 reference

7 January 2021

Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration

1 reference

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

7 January 2021

Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis

1 reference

7 January 2021

[Initial symptoms, survival and causes of death in 115 patients with frontotemporal lobar degeneration]

1 reference

7 January 2021

Neurons and their dendrites in frontotemporal dementia

1 reference

7 January 2021

1 reference

7 January 2021

The Bayer Activities of Daily Living Scale (B-ADL).

1 reference

7 January 2021

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

1 reference

7 January 2021

Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia

1 reference

7 January 2021

Rivastigmine in frontotemporal dementia: an open-label study.

1 reference

7 January 2021

Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study

1 reference

7 January 2021

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients

1 reference

7 January 2021

Overview of frontotemporal dementias and the consensus applied

1 reference

7 January 2021

Frontotemporal dementia: a randomised, controlled trial with trazodone

1 reference

7 January 2021

Natural history of frontotemporal dementia: comparison with Alzheimer's disease.

1 reference

7 January 2021

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

7 January 2021

Neurochemical features of frontotemporal dementia

1 reference

7 January 2021

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

1 reference

7 January 2021

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

1 reference

7 January 2021

FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation

1 reference

7 January 2021

Memantine for behavioral disturbances in frontotemporal dementia: a case series

1 reference

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

7 January 2021

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.1973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18213609%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference